Scarica l'app Stockscreener
67.56
0.45%
0.275
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché BMY Giù?
Forum
Previsione
Frazionamento azionario
Storia dei dividendi
Bristol Myers Squibb Co Borsa (BMY) Ultime notizie
Bristol-Myers Squibb (BMY) Bets $2.3 Billion on Texas While Eli Lilly (LLY) Wins in the UK - Yahoo Finance
Why Bristol Myers Squibb (BMY) Stock Is Up Today - Quiver Quantitative
Bristol-Myers Squibb Co Stock (BMY) Moved Up by 3.06% on Aug 21: Drivers Behind the Movement - TradingKey
BMY|Bristol-Myers Squibb Co|Price:67.010|Chg%:+1.540 - TradingKey
Can Eliquis Cushion Bristol Myers' Legacy Portfolio Erosion? - Yahoo Finance
Roundup: Amplitude Therapeutics, Chai Discovery Enter Collaborations with Eli Lilly, Bristol Myers Squibb - Pharmaceutical Executive
Chai partners with Bristol Myers Squibb on AI-driven antibody discovery - The Pharma Letter
Paralel Advisors LLC Acquires Shares of 38,091 Bristol Myers Squibb Company $BMY - MarketBeat
104,121 Shares in Bristol Myers Squibb Company $BMY Bought by TrinityBridge Ltd - MarketBeat
OneAscent Financial Services LLC Takes Position in Bristol Myers Squibb Company $BMY - MarketBeat
LaSalle St. Investment Advisors LLC Takes $1.12 Million Position in Bristol Myers Squibb Company $BMY - MarketBeat
Tocqueville Asset Management L.P. Invests $5.30 Million in Bristol Myers Squibb Company $BMY - MarketBeat
Vise Technologies Inc. Acquires Shares of 141,913 Bristol Myers Squibb Company $BMY - MarketBeat
Bank of New York Mellon Corp Decreases Stake in Bristol Myers Squibb Company $BMY - MarketBeat
Allworth Financial LP Makes New Investment in Bristol Myers Squibb Company $BMY - MarketBeat
Bristol Myers Squibb stock edges higher as AI antibody deal and Q2 earnings support outlook - Ad-hoc-news.de
Hillman Value Fund's Bristol-Myers Squibb Co(BMY) Holding History - GuruFocus
Bristol-Myers Squibb Co (BMY) Shares Fall 3.2% -- GF Value Says Still Overvalued - GuruFocus
Bristol Myers Squibb Co. stock underperforms Thursday when compared to competitors - MarketWatch
Bristol-Myers Squibb Co Stock (BMY) Closed Down by 3.17% on Aug 20: Facts Behind the Movement - TradingKey
UBS reiterates Buy on Bristol-Myers Squibb stock, $80 target - Investing.com
Why Bristol Myers, Johnson & Johnson and More Are Watching Seaport After IPO - AOL.com
Chai tees up Bristol Myers Squibb AI antibody discovery collab - Fierce Biotech
UBS reiterates Buy on Bristol-Myers Squibb stock, $80 target By Investing.com - Investing.com Canada
Bristol Myers Squibb stock steadies as FDA approval and Houston expansion reshape outlook - Ad-hoc-news.de
Bristol-Myers Squibb partners with Chai Discovery to leverage AI in developing new therapies - 富途牛牛
Bristol Myers Squibb, Chai Partner on AI Antibody Discovery - Contract Pharma
Chai Discovery Announces Collaboration with Bristol Myers Squibb to Advance AI-Driven Antibody Discovery - Business Wire
United Bank Acquires New Holdings in Bristol Myers Squibb Company $BMY - MarketBeat
Johnson Financial Group Inc. Buys Shares of 21,307 Bristol Myers Squibb Company $BMY - MarketBeat
33,580 Shares in Bristol Myers Squibb Company $BMY Acquired by one8zero8 LLC - MarketBeat
Patrick Mauro Investment Advisor INC. Acquires New Position in Bristol Myers Squibb Company $BMY - MarketBeat
Knuff & Co LLC Acquires New Holdings in Bristol Myers Squibb Company $BMY - MarketBeat
Edmond DE Rothschild Holding S.A. Acquires Shares of 113,537 Bristol Myers Squibb Company $BMY - MarketBeat
Bell & Brown Wealth Advisors LLC Invests $2.46 Million in Bristol Myers Squibb Company $BMY - MarketBeat
Abacus FCF Advisors LLC Makes New $13.11 Million Investment in Bristol Myers Squibb Company $BMY - MarketBeat
Bristol Myers Squibb Co. stock outperforms competitors on strong trading day - MarketWatch
Stock Traders Buy High Volume of Bristol Myers Squibb Call Options (NYSE:BMY) - MarketBeat
Bristol Myers Squibb (NYSE:BMY) Sets New 52-Week HighWhat's Next? - MarketBeat
Bristol-Myers Squibb stock hits 52-week high at 68.1 USD - Investing.com
AstraZeneca Vs. Bristol-Myers Squibb: Who’s The Better Bargain For Investors (NYSE:BMY) - Seeking Alpha
FESTIVAL ANNOUNCEMENT: 32nd Annual One Mind Music Festival Presented by Bank of America and Bristol Myers Squibb - 巴士的報
FESTIVAL ANNOUNCEMENT: 32nd Annual One Mind Music Festival Presented by Bank of America and Bristol Myers Squibb – Company AnnouncementFT.com - Financial Times
Hematogenix's MM MRD Assay Underpins FDA Accelerated Approval of Bristol Myers Squibb's ZENBEXUS™, the First Approved CELMoD Therapy for Multiple Myeloma - Yahoo Finance
Why Novartis, Lilly, and Bristol Myers Are Eyeing This Clinical-Stage Cancer Play - AOL.com
Bristol Myers Squibb to build $2.3B manufacturing campus in Houston - Yahoo Finance
Bristol-Myers Squibb stock holds gains as Zenbexus approval and fresh guidance shape the outlook - AD HOC NEWS
Bristol Myers Squibb Company $BMY Holdings Trimmed by Pzena Investment Management LLC - MarketBeat
Great Lakes Advisors LLC Makes New Investment in Bristol Myers Squibb Company $BMY - MarketBeat
Danica Pension Livsforsikringsaktieselskab Buys New Stake in Bristol Myers Squibb Company $BMY - MarketBeat
Diversify Advisory Services LLC Invests $2.33 Million in Bristol Myers Squibb Company $BMY - MarketBeat
Danske Bank A S Acquires Shares of 1,501,133 Bristol Myers Squibb Company $BMY - MarketBeat
BlackRock Inc. Raises Position in Bristol Myers Squibb Company $BMY - MarketBeat
17,077 Shares in Bristol Myers Squibb Company $BMY Purchased by Avaii Wealth Management LLC - MarketBeat
16,000 Shares in Bristol Myers Squibb Company $BMY Acquired by Alpine Woods Capital Investors LLC - MarketBeat
Bristol-Myers Squibb Adds Early Alzheimer’s Antibody To Its Long-Term Growth Story - TipRanks
Schrödinger (SDGR) Turns Profitable As Bristol Myers Squibb Deal Tests Its Valuation - simplywall.st
Bristol-Myers Squibb Co (BMY) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
Bristol Myers Squibb Co. stock underperforms Tuesday when compared to competitors despite daily gains - MarketWatch
Biokin bispecific ADC iza-bren hits goal in lung cancer trial, boosting case for BMS’ global test - Fierce Pharma
Bristol Myers Squibb (BMY) Stock May Be 46% Below Fair Value As FDA Approval Lands - simplywall.st
49,346 Shares in Bristol Myers Squibb Company $BMY Acquired by Trust Co. of Vermont - MarketBeat
Bristol Myers Squibb Company $BMY Shares Purchased by Mitsubishi UFJ Asset Management Co. Ltd. - MarketBeat
Deutsche Bank AG Acquires 1,106,696 Shares of Bristol Myers Squibb Company $BMY - MarketBeat
Focus Partners Advisor Solutions LLC Reduces Stock Position in Bristol Myers Squibb Company $BMY - MarketBeat
Flputnam Investment Management Co. Raises Stock Position in Bristol Myers Squibb Company $BMY - MarketBeat
PENN DAVIS MCFARLAND INC's Bristol-Myers Squibb Co(BMY) Holding History - GuruFocus
Backed by a massive $2.3 billion investment, a brand-new 600,000-square-foot biopharmaceutical manufacturing campus is officially heading to Houston - Secret Houston
Bristol Myers Squibb stock holds in the low $60s as new multiple myeloma drug class debuts - AD HOC NEWS
2.00%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):